Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,165-1,176 of 1,745
Drug study icon
CompletedNCT00700427

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
ADHDDrugFrom 18 Years to 50 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Other study type icon
CompletedEUCTR 2008-001581-91

Safety study of Lu AA21004 in depression

This study is completed in France, in the United Kingdom, in Germany, .... It is testing Lu AA21004 for depression.

In United Kingdom
DepressionOther
Countries
France, United Kingdom, Germany, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd.
Condition
Depression
Other study type icon
CompletedEUCTR 2007-003035-22

ACP-103 for Schizophrenia

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing ACP-103 for Schizophrenia.

In United Kingdom
SchizophreniaOther
Countries
France, United Kingdom, Belgium, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Other study type icon
TerminatedEUCTR 2012-003228-19

Safety study of Safety and Clinical Effects of Prolonged Exposure to 1 and 2 mg Doses of EVP-6124, an Alpha- 7 Nicotinic Acetylcholine Receptor Agonist, in Schizophrenia

This study was terminated in the United Kingdom, in Spain, in Germany, .... It is testing Safety and Clinical Effects of Prolonged Exposure to 1 and 2 mg Doses of EVP-6124, an Alpha- 7 Nicotinic Acetylcholine Receptor Agonist, for Schizophrenia.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom, Spain, Germany, ...
Sponsor
EnVivo Pharmaceuticals, Inc.
Condition
Schizophrenia
Other study type icon
OngoingEUCTR 2010-024371-12

BMS-820836 for depression

This study is ongoing in the United Kingdom, in Spain, in Sweden, .... It is testing BMS-820836 for depression.

In United Kingdom
DepressionOther
Countries
United Kingdom, Spain, Sweden, ...
Sponsor
Bristol-Myers Squibb International Corporation
Condition
Depression
Drug study icon
CompletedEUCTR 2004-002560-17

Asenapine With Olanzapine for Schizophrenia

This study is completed in the United Kingdom, in Finland, in Denmark, .... It is testing asenapine With Olanzapine for Schizophrenia.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom, Finland, Denmark, ...
Sponsor
NV Organon
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.